References
- Quadri F, Mazer-Amirshahi M, Fox ER, et al. Antibacterial drug shortages from 2001 to 2013: implications for clinical practice. Clin Inf Dis. 2015;60:1737–1742.
- Fox ER, Tyler LS. Managing drug shortages: seven years experience at one health system. Am J Health System Pharm. 2003;60:245–253.
- Griffith MM, Pentoney Z, Scheetz MH. Antimicrobial drug shortages: a crisis amidst the epidemic and the need for antimicrobial stewardship efforts to lessen the effects. Pharmacotherapy. 2012;32:665–667.
- Thursky K. Piperacillin-Tazobactam. In: Grayson ML, editor. Kucers the use of antibiotics. 2010. pp 238–254.
- Cunha BA, editor. Antibiotic essentials. 14th edn. JP Medical Publishers: New Delhi: JayPee Medical Publishers, 2015. pp 92–97, 107–12, 541–714.
- Skodvin B, Aase K, Charani E, et al. An antimicrobial stewardship program initiative: a qualitative study on rescribing practices among hospital doctors. Anti Res and Inf Cont. 2015;4:24–31.
- Pukini C, Botelho-Nevers E, Dyar OJ, Harbarth S. The impact of infectious disease specialists on antibiotic prescribing in hospitals. Clin Microbiol Infect. 2014;20:963–972.
- Rattanaumpawan P, Morales KH, Binkley S, et al. Impact of antimicrobial stewardship programme changes on unnecessary double anaerobic coverage therapy. J Antimicrob Chemo. 2011;66:2655–2658.
- Talpart MJ, Gopal Rao G, Cooper BS, Wade P. Impact guidelines and enhanced antibiotic stewardship on reducing broad spectrum antibiotic usage and its effect on incidence of C. difficile infection. J Antimicrob Chemo. 2011;66:2168–2174.
- Cunha CB, Varughese CA, Mylonakis E. Antimicrobial stewardship programs (ASPs). The Devil is in the Details. Virulence. 2013;4:147–149.